Loannis Hodges-Mameletzis will be speaking on ‘International PrEP Research agenda: Current guidelines and future plans’. He trained as a chronic disease epidemiologist at Yale University’s School of Public Health and holds a doctorate at the University of Oxford studying HIV molecular evolution, with a special focus on HIV-2 infection – the non-pandemic strain of HIV primarily found in West Africa with a striking association of an attenuated phenotype. He is a Consultant on pre-exposure prophylaxis (PrEP), HIV Department at World Health Organization
Nelly Mugo will be speaking on ‘Partners PrEP study outcomes and implications for ending HIV by 2030’. Dr. Nelly R. Mugo is an obstetrician, gynecologist and a principal research scientist at the Kenya Medical Research Institute (KEMRI), Nairobi.She attained her medical training at the University of Nairobi and earned her MPH with a major in epidemiology tract from University of Washington in 2000. Her research focus is on HIV prevention and reproductive health research. Presently, she collaborates with the University of Washington, International Clinical Research Center (ICRC) and she is the principal investigator for Partners in Health
Nyaradzo Mgodi will be speaking on ‘What is new in the biomedical HIV prevention field’. She served as co-investigator for VOICE and as lead investigator for the VOICE Bone Mineral Density Sub-study. Currently she is the lead investigator for ASPIRE (a large phase III clinical trial assessing the safety and effectiveness of Dapivirine Vaginal Ring in the prevention of HIV-1) and HPTN-076 (a Phase II Safety and Acceptability trial of an Investigational Injectable TMC 278 LA for PrEP). She is also protocol co-chairperson for HOPE, the planned open label extension study to ASPIRE.